Jun

25

2022

What do I do for a patient with cancer and recurrent venous thromboembolic events despite receiving therapeutic mow-molecular-weight heparin (LMWH)?

By William Aird

A

What do I do for a patient with cancer and recurrent venous thromboembolic events despite receiving therapeutic mow-molecular-weight heparin (LMWH)?

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer:

Stay Updated

If you are interested in getting the latest articles from The Blood Project, enter your name and email

  • This field is for validation purposes and should be left unchanged.